drug

modified cognitive behavioural therapy (mCBT)

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by University of Cologne
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis
NCT00465920Phase 2Unknown

KOLs & investigators

1
Andreas Bechdolf, PD Dr.

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of Cologne
company
trial
Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis
PHASE2
trial
indication
Schizophrenia
indication
Schizophreniform Disorder
indication
Schizophrenia
indication
Delusional Disorder
indication
KOL
Andreas Bechdolf, PD Dr.
KOL score —
person